f Significant progress toward the control of malaria has been achieved, especially regarding Plasmodium falciparum infections. However, the unique biology of Plasmodium vivax hampers current control strategies. The early appearance of P. vivax gametocytes in the peripheral blood and the impossibility of culturing this parasite are major drawbacks. Using blood samples from 40 P. vivax-infected patients, we describe here a methodology to purify viable gametocytes and further infect anophelines. This method opens new avenues to validate transmission-blocking strategies.
I
n a scenario of malaria elimination, strategies based on transmission control, rapid diagnosis, effective vaccines, and specific drugs are vital. Early diagnosis and prompt treatment with effective drugs have led to a considerable decrease in the number of cases of falciparum malaria worldwide (1) . However, the control and elimination of Plasmodium vivax still constitute a great challenge due to specific features of the organism, including gametocytes on peripheral blood early during infection (2) , occurrence of a dormant stage in the liver (hypnozoite), and the emergence of drug-resistant forms (3, 4) . The development of transmissionblocking molecules to reduce transmission is crucial for malaria eradication. However, because of the lack of a robust continuous in vitro culture system (5), studies on P. vivax gametocytes have been hampered. Here, using blood samples from 40 P. vivax-infected patients and membrane feeding assays, we describe a unique methodology to purify and concentrate viable gametocytes capable of infecting anophelines. This methodology opens avenues for testing drugs or vaccines against the gametocytes, the nonreplicating sexual stage responsible for parasite transmission to mosquitoes (2) .
Patients were recruited at the Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (FMT-HVD), a tertiary care center for infectious diseases in Manaus, Amazonas State, Brazil. This study was approved by a Brazilian ethics board (CAAE 0044.0.114.000-11). Up to 9 ml of peripheral blood was collected from infected patients, with parasitemia ranging from 297.5 to 30,600 parasites/l and gametocytemia (mean Ϯ standard deviation [SD]) of 13.3% Ϯ 16.7%. White blood cells were removed from the blood using a cellulose column (Sigma), as previously described (6) . Afterwards, to separate asexual and sexual parasites from noninfected erythrocytes, we used a Percoll-45% (P45) or Percoll-60% (P60) gradient (7, 8) and/or magnetic purification (MP) using MACS-Columns LD/LS (Miltenyi Biotec) (9) . Blood samples were maintained at 37°C during all procedures to avoid gametocyte exflagellation. For this purpose, we used a hot plate inside the tissue culture hood and preheated solutions, and all centrifugations were performed at 37°C. The percentage of gametocytes was determined by counting parasites on thin Giemsa smears before and after the purification process. Correlations were analyzed using the Spearman test. The normality of the data was evaluated with the Kolmogorov-Smirnov test. Comparisons between groups were analyzed using the Mann-Whitney U test (two groups) or the Kruskal-Wallis test. Statistical analyses were performed using GraphPad Prism version 6.
The P45 treatment led to the recovery of trophozoites, schizonts, and gametocytes. A considerable percentage of parasites at the gametocyte stage was obtained (mean Ϯ SD, 44.1% Ϯ 33.88%; Fig. 1A ) and a considerable amount of trophozoites as well (50.3% Ϯ 34.17). Moreover, by performing MP after the P45 treatment, we were not able to improve the gametocyte purity (54.3% Ϯ 41.65%, P ϭ 0.70) or the parasitemia (47.7% Ϯ 50.54%, P ϭ 0.46) (Fig. 1A and B) . In contrast, after P60 purification, gametocytes were recovered, with low percentages of other parasite stages (gametocytes, 81.6% Ϯ 30.50%; Fig. 1A ). Despite the high degree of purification, noninfected erythrocytes were also found in the P60 interphase that contained gametocytes (parasitemia, 18.9% Ϯ 27.34%) (Fig. 1B) . The P60 procedure rendered significantly higher percentages of gametocytes than those with the P45 procedure (81.6% versus 44.15%, P ϭ 0.0049).
Performing MP after the P60 procedure did not improve the percentage of gametocytes recovered (79.9% Ϯ 38.64%, P ϭ 0.54) or the parasitemia level (34.7% Ϯ 40.49%, P ϭ 0.65).
Nevertheless, when the MP method was applied alone, we obtained a gametocytemia of 62.13% Ϯ 39.20% (Fig. 1A) and a parasitemia of 53.8% Ϯ 45.74% (Fig. 1B) . This procedure allowed us to enrich for parasites with large amounts of hemozoin, resulting in only the mature asexual stage (Ͼ30 h) and gametocytes retained on the magnetic column (9) . No association between the yield of gametocytes after purification and the initial gametocytemia of the patients was found (Fig. 1C) . Figure 1D shows a step-by-step schematic flow of all purification procedures.
Considering that robust drug tests rely on parasite viability and infectivity, we conducted the artificial membrane feeding assays only after we established the procedures to purify and increase the number of gametocytes. Those assays were performed using an established colony of the Anopheles aquasalis mosquito vector, as described elsewhere (10) . Successful infections were determined by the presence of oocysts in the midgut of the mosquitoes.
A. aquasalis, Anopheles albitarsis, and Anopheles darlingi are the main vectors in South America and are associated with malaria transmission (11) . A. aquasalis has successfully been used under laboratory conditions for P. vivax infections (10) , and an infection protocol with P. vivax on A. darlingi was recently established (12) . For these assays, purified gametocytes were used to prepare blood dilutions at a hematocrit level of 36% using washed uninfected fresh Oϩ blood and AB serum at a final volume of 1 ml. Next, 100 mosquitoes were fed on these samples and reared accordingly (10) . Prior to infection, the viability of the gametocytes was tested by exflagellation assays. Briefly, 10 l of purified gametocytes and autologous serum were placed on a microscope slide for 10 min, and exflagellation was visualized with the aid of a light microscope (Fig. 2A) . Step-by-step schematic and comparative representation of the three procedures.
The capacity of P. vivax purified gametocytes to infect mosquitoes was evaluated in P45 purification and confirmed by the visualization of oocysts in the midgut (Fig. 2B) . As shown in Fig. 2C , the infectivity rate of mosquitoes fed with dilutions prepared with P45 purified gametocytes ranged from 25.0% to 73.1% (mean Ϯ SD, 54.0% Ϯ 15.2%). The median number of oocysts produced in mosquitoes fed with P. vivax P45 purified gametocytes was 4.0 (interquartile range [IQR], 2.0 to 8.0 oocysts). Moreover, we found no correlation between the number of gametocytes given to mosquitoes and the infection rate (Fig. 2D) or the number of oocysts in infected mosquitoes (Fig. 2E) . These data, a representation of the results from 8 independent experiments ( Fig. 2A to C) , demonstrate that the purified gametocytes were viable (exflagellation) and infective (oocyst production in the midgut of the mosquitoes).
Based on the different gametocyte purification method outcomes, the choice of procedure will depend on the goal to be achieved. The P60 method will be more appropriate for obtaining gametocytes in the absence of asexual parasite stages. To achieve high concentrations of parasites, the use of P45 or MP alone will be the best choice, because the combination of these methodologies (P45 plus MP or P60 plus MP) did not improve the gametocytemia or parasitemia levels. Collectively, these data validate a methodology to purify viable and infective P. vivax gametocytes, assisting in the discovery of new antimalarial drug leads and vaccine candidates. 
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